Trans Abdominal Plane Block (TAP Block) in Surgery of Stoma Reversal and Its Effect on Post Operative Recovery: a Prospective, Randomized, Muticenter Study
Tapas
2 other identifiers
interventional
149
1 country
2
Brief Summary
The primary purpose of TAPAS study is to demonstrate the superiority of analgesic effect of trans abdominal plane block (TAP block) performed at the beginning of stoma reversal, compared to standard of care. The hypothesize is that a TAP block performed at the beginning of surgery of stoma reversal would improve patient's satisfaction (evaluated by Quo-r40 questionnaire), would reduce the incidence of post operative pain, time spent in recovery room, and reduce hospitalisation time
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable surgery
Started Jun 2019
Longer than P75 for not_applicable surgery
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2019
CompletedFirst Posted
Study publicly available on registry
June 3, 2019
CompletedStudy Start
First participant enrolled
June 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 17, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 17, 2023
CompletedApril 18, 2023
April 1, 2023
3.8 years
May 20, 2019
April 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quo 40 score
Once the patient is transferred in post operative surgical service, assessment of the primary outcome will be done by the physician in charge of the patient. Quo 40 score is a postoperative recovery score above 200 points validated by Myles et al in 2001.
Day 1 (
Secondary Outcomes (5)
NRS (Numeric rating scale)
Day 1 : At the entrance of recovery room
NRS (Numeric rating scale)
Day 1
NRS (Numeric rating scale)
Day 2
Quo 40 score
Day 15
Time spent in recovery room
At the output of recovery room ie until 6 hours after intervention
Study Arms (2)
usual practice
NO INTERVENTIONControl group (usual practice): patients receiving a general anaesthesia with propofol, sufentanyl and cisatracurium for the induction, and sevoflurane, sufentanyl and cisatracurium for the maintenance. Patients receiving a multimodal intravenous analgesia, with acetaminophen, ketoprophen, nefopam and morphine. if necessary. Antimicrobial prophylaxis is performed according to recommendations
TAP block
EXPERIMENTALIn addition of usual practice, patients receiving a TAP block at the beginning of the surgery
Interventions
Trans abdominal plane block is performed with ultra sound guidance. 1. \- The high frequency probe is placed right to the umbilicus, and slips laterally to the side to block. It allows showing the three belts of larges muscles of abdomen (External Oblicum, internal oblicum, and transversal of the abdomen). 2. \- When the needle is visualised in the plan separating the muscle internal oblicum and transversal of the abdomen, 20 ml of ropivacaïne 5mg/ml are injected after aspiration test. If in doubt, hydro localisation car be realised.
Eligibility Criteria
You may qualify if:
- Age \> 18 years old
- Patients operated of a scheduled stoma reversal surgery
- Patients having given consent in the mannen described in Article L1122-1-1 of the Public Health Code
- Patients affiliated with asocial security regimen or beneficiary of such a regimen
You may not qualify if:
- Renal insufficiency (ie glomerular filtration output \< 35 ml/min)
- Patients with chronic inflammatory bowel disease
- Body mass index \> 35 kg/m2
- Chronic pain with opiates
- Patients with cognitive troubles
- Coagulation disorders (platelets count \< 80G/L, PT\< 50%, V factor \< 50%)
- Pregnancy
- Breastfeeding
- Local anesthesics (amide class) allergy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHU
Clermont-Ferrand, France
CHU Rennes
Rennes, 35033, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie Vignaud
CHU Clermont-Ferrand.fr
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2019
First Posted
June 3, 2019
Study Start
June 17, 2019
Primary Completion
April 17, 2023
Study Completion
April 17, 2023
Last Updated
April 18, 2023
Record last verified: 2023-04